Fairmount Funds Management LLC
Related Filers (23)
- Fairmount Healthcare Fund II L.P. (14)
- Fairmount Healthcare Fund L.P. (14)
- Viridian Therapeutics, Inc.\DE (12)
- Harwin Peter Evan (12)
- Kiselak Tomas (12)
- Cogent Biosciences, Inc. (10)
- Spyre Therapeutics, Inc. (8)
- Dianthus Therapeutics, Inc. /DE/ (8)
- Fairmount Healthcare Fund GP LLC (7)
- Fairmount Healthcare Fund II GP LLC (7)
- Astria Therapeutics, Inc. (5)
- Apogee Therapeutics, Inc. (5)
- Axsome Therapeutics, Inc. (4)
- Fairmount Healthcare Co-Invest L.P. (4)
- Annexon, Inc. (3)
- Trevi Therapeutics, Inc. (3)
- Terns Pharmaceuticals, Inc. (3)
- Nuvalent, Inc. (3)
- Olema Pharmaceuticals, Inc. (2)
- Enliven Therapeutics, Inc. (2)
- Fairmount Healthcare Co-Invest II L.P. (2)
- Kiniksa Pharmaceuticals, Ltd. (2)
- SOLENO THERAPEUTICS INC (1)
- Show More ...
Other (17)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/9/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/13/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/14/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/12/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/12/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/4/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/8/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/12/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (71)
SC 13D/A
Friday, 2/16/2024
Cogent Biosciences, Inc.: Major Shareholders
4
Friday, 2/16/2024
Cogent Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/14/2024
Terns Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Axsome Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Astria Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Trevi Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Nuvalent, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Annexon, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Kiniksa Pharmaceuticals, Ltd.: Major Shareholders
4
Wednesday, 1/31/2024
Apogee Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 1/31/2024
Apogee Therapeutics, Inc.: Major Shareholders
4
Wednesday, 1/24/2024
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 1/24/2024
Dianthus Therapeutics, Inc. /DE/: Major Shareholders
4
Wednesday, 1/24/2024
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 1/24/2024
Viridian Therapeutics, Inc.\DE: Major Shareholders
4
Friday, 12/29/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/29/2023
Spyre Therapeutics, Inc.: Major Shareholders
4
Monday, 12/11/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 12/11/2023
Spyre Therapeutics, Inc.: Major Shareholders
SC 13D/A
Wednesday, 11/29/2023
Spyre Therapeutics, Inc.: Major Shareholders
4
Tuesday, 11/28/2023
Spyre Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 11/3/2023
Viridian Therapeutics, Inc.\DE: Major Shareholders
4
Wednesday, 11/1/2023
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 10/10/2023
SOLENO THERAPEUTICS INC: Major Shareholders
4
Tuesday, 10/3/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Thursday, 9/28/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
4
Thursday, 9/21/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 9/21/2023
Dianthus Therapeutics, Inc. /DE/: Major Shareholders
3
Wednesday, 9/13/2023
Dianthus Therapeutics, Inc. /DE/: Initial statement of beneficial ownership of securities
4
Wednesday, 9/13/2023
Dianthus Therapeutics, Inc. /DE/: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 8/10/2023
Kiniksa Pharmaceuticals, Ltd.: Major Shareholders
SC 13D
Friday, 7/21/2023
Apogee Therapeutics, Inc.: Major Shareholders
4
Monday, 7/17/2023
Apogee Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/13/2023
Apogee Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 7/7/2023
Axsome Therapeutics, Inc.: Major Shareholders
3
Friday, 6/30/2023
Aeglea BioTherapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 6/30/2023
Aeglea BioTherapeutics, Inc.: Major Shareholders
4
Tuesday, 6/13/2023
Cogent Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 6/13/2023
Cogent Biosciences, Inc.: Major Shareholders
SC 13G
Thursday, 4/27/2023
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Trevi Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Annexon, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Terns Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Nuvalent, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Astria Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Axsome Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 11/9/2022
Nuvalent, Inc.: Major Shareholders
SC 13G
Wednesday, 10/26/2022
Axsome Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 8/25/2022
Terns Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 8/19/2022
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 8/19/2022
Viridian Therapeutics, Inc.\DE: Major Shareholders
4
Tuesday, 6/21/2022
Cogent Biosciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 6/21/2022
Cogent Biosciences, Inc.: Major Shareholders
SC 13G
Thursday, 4/21/2022
Trevi Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 4/21/2022
Annexon, Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/8/2022
Astria Therapeutics, Inc.: Major Shareholders
4
Thursday, 9/23/2021
Viridian Therapeutics, Inc.\DE: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 9/23/2021
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Wednesday, 9/22/2021
Astria Therapeutics, Inc.: Major Shareholders
SC 13G
Thursday, 6/17/2021
CATABASIS PHARMACEUTICALS INC: Major Shareholders
SC 13D
Tuesday, 1/5/2021
MIRAGEN THERAPEUTICS, INC.: Major Shareholders
3
Friday, 10/30/2020
MIRAGEN THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 10/30/2020
MIRAGEN THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/29/2020
MIRAGEN THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 7/13/2020
Unum Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 7/10/2020
Unum Therapeutics Inc.: Major Shareholders
3
Wednesday, 7/8/2020
Unum Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/8/2020
Unum Therapeutics Inc.: Statement of changes in beneficial ownership of securities